{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:00:18Z","timestamp":1791349218731,"version":"4.3.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100001819","name":"International Rett Syndrome Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001819","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Rett Syndrome Research Trust"}],"content-domain":{"domain":["clinicalkey.jp","thebonejournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.bone.2017.03.040","type":"journal-article","created":{"date-parts":[[2017,3,18]],"date-time":"2017-03-18T10:47:00Z","timestamp":1489834020000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Zoledronic acid improves bone histomorphometry in a murine model of Rett syndrome"],"prefix":"10.1016","volume":"99","author":[{"given":"Jay R.","family":"Shapiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele L.","family":"Boskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9072-793X","authenticated-orcid":false,"given":"Stephen B.","family":"Doty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyudmila","family":"Lukashova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8322-9972","authenticated-orcid":false,"given":"Mary E.","family":"Blue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2017.03.040_bb0005","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2","volume":"23","author":"Amir","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bone.2017.03.040_bb0010","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1469-7610.2008.02046.x","article-title":"Childhood developmental disorders: an academic and clinical convergence point for psychiatry, neurology, psychology and pediatrics","volume":"50","author":"Reiss","year":"2009","journal-title":"J. Child Psychol. Psychiatry"},{"key":"10.1016\/j.bone.2017.03.040_bb0015","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1002\/ana.22124","article-title":"Rett syndrome: revised diagnostic criteria and nomenclature","volume":"68","author":"Neul","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bone.2017.03.040_bb0020","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.neuron.2007.10.001","article-title":"The story of Rett syndrome: from clinic to neurobiology","volume":"56","author":"Chahrour","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.bone.2017.03.040_bb0025","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/mrdd.10027","article-title":"Neuropathology of Rett syndrome","volume":"8","author":"Armstrong","year":"2002","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"issue":"Suppl. 1","key":"10.1016\/j.bone.2017.03.040_bb0030","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1016\/j.braindev.2004.10.008","article-title":"MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution","volume":"27","author":"Kaufmann","year":"2005","journal-title":"Brain Dev."},{"key":"10.1016\/j.bone.2017.03.040_bb0035","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.nbd.2007.04.005","article-title":"Mecp2 deficiency leads to delayed maturation and altered gene expression in hippocampal neurons","volume":"27","author":"Smrt","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bone.2017.03.040_bb0040","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1177\/08830738050200082601","article-title":"Rett syndrome and neuronal development","volume":"20","author":"Johnston","year":"2005","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.bone.2017.03.040_bb0045","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/ana.10633","article-title":"Olfactory biopsies demonstrate a defect in neuronal development in Rett's syndrome","volume":"54","author":"Ronnett","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bone.2017.03.040_bb0050","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1126\/science.1153252","article-title":"MeCP2, a key contributor to neurological disease, activates and represses transcription","volume":"320","author":"Chahrour","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.bone.2017.03.040_bb0055","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bone.2015.01.024","article-title":"Osteoblast function and bone histomorphometry in a murine model of Rett syndrome","volume":"76","author":"Blue","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.03.040_bb0060","first-page":"446","article-title":"Bone mass in Rett syndrome: association with clinical parameters and MECP2 mutations","volume":"68","author":"Shapiro","year":"2010","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.bone.2017.03.040_bb0065","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1203\/PDR.0b013e318180ebcd","article-title":"Bone mineral content and bone mineral density are lower in older than in younger females with Rett syndrome","volume":"64","author":"Motil","year":"2008","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.bone.2017.03.040_bb0070","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1542\/peds.2007-1641","article-title":"Early determinants of fractures in Rett syndrome","volume":"121","author":"Downs","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.bone.2017.03.040_bb0075","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1002\/jbmr.423","article-title":"DXA measurements in Rett syndrome reveal small bones with low bone mass","volume":"26","author":"Roende","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.03.040_bb0080","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0146824","article-title":"Clinical guidelines for management of bone health in Rett syndrome based on expert consensus and available evidence","volume":"11","author":"Jefferson","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2017.03.040_bb0085","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1007\/s00198-013-2423-5","article-title":"Osteoporosis in Rett syndrome: a case study presenting a novel management intervention for severe osteoporosis","volume":"24","author":"Lotan","year":"2013","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2017.03.040_bb0090","first-page":"253","article-title":"Teriparatide in the treatment of recurrent fractures in a Rett patient","volume":"12","author":"Caffarelli","year":"2015","journal-title":"Clin. Cases Miner. Bone Metab."},{"key":"10.1016\/j.bone.2017.03.040_bb0095","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1007\/s00198-016-3586-7","article-title":"Bone microarchitecture in Rett syndrome and treatment with teriparatide: a case report","volume":"27","author":"Zanchetta","year":"2016","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2017.03.040_bb0100","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/85899","article-title":"A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome","volume":"27","author":"Guy","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bone.2017.03.040_bb0105","first-page":"48648","article-title":"Safety & efficacy of cyclic zoledronic acid therapy on pediatric secondary osteoporosis","volume":"8","author":"Al-Agha","year":"2016","journal-title":"Glob. J. Health Sci."},{"key":"10.1016\/j.bone.2017.03.040_bb0110","doi-asserted-by":"publisher","first-page":"4163","DOI":"10.1210\/jc.2015-2680","article-title":"Short-term safety of zoledronic acid in young patients with bone disorders: an extensive institutional experience","volume":"100","author":"George","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2017.03.040_bb0115","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000354303","article-title":"Intravenous zoledronic acid given every 6 months in childhood osteoporosis","volume":"80","author":"Ooi","year":"2013","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.bone.2017.03.040_bb0120","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.neuroscience.2006.01.060","article-title":"Temporal shift in methyl-CpG binding protein 2 expression in a mouse model of Rett syndrome","volume":"139","author":"Metcalf","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.bone.2017.03.040_bb0125","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cyto.2016.03.012","article-title":"Zoledronic acid increases the circulating soluble RANKL level in mice, with a further increase in lymphocyte-derived soluble RANKL in zoledronic acid- and glucocorticoid-treated mice stimulated with bacterial lipopolysaccharide","volume":"83","author":"Abe","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.bone.2017.03.040_bb0130","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1359\/jbmr.071207","article-title":"Long-term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat","volume":"23","author":"Gasser","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.03.040_bb0135","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.bone.2011.05.013","article-title":"MicroCT morphometry analysis of mouse cancellous bone: intra- and inter-system reproducibility","volume":"49","author":"Verdelis","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.03.040_bb0140","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.03.040_bb0145","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1177\/002215549704500215","article-title":"Embedding of bone samples in methylmethacrylate: an improved method suitable for bone histomorphometry, histochemistry, and immunohistochemistry","volume":"45","author":"Erben","year":"1997","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.bone.2017.03.040_bb0150","first-page":"38","article-title":"Skeletal effects of fibroblast growth factor mimetic (F2A) in ovariectomized rats","volume":"9","author":"Aguirre","year":"2009","journal-title":"J. Musculoskelet. Neuronal Interact."},{"key":"10.1016\/j.bone.2017.03.040_bb0155","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1359\/jbmr.070906","article-title":"Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure","volume":"23","author":"Recker","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.03.040_bb0160","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR histomorphometry nomenclature committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.03.040_bb0165","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0093-7754(01)90263-5","article-title":"Preclinical studies with zoledronic acid and other bisphosphonates: impact on the bone microenvironment","volume":"28","author":"Mundy","year":"2001","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.bone.2017.03.040_bb0170","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1210\/en.2013-1993","article-title":"Effect of bisphosphonates on the rapidly growing male murine skeleton","volume":"155","author":"Zhu","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2017.03.040_bb0175","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.bone.2009.04.251","article-title":"Mecp2 deficiency decreases bone formation and reduces bone volume in a rodent model of Rett syndrome","volume":"45","author":"O'Connor","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.03.040_bb0180","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1097\/MPG.0000000000000440","article-title":"Low bone mineral mass is associated with decreased bone formation and diet in girls with Rett syndrome","volume":"59","author":"Motil","year":"2014","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.bone.2017.03.040_bb0185","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1177\/08830738030180100401","article-title":"Possible mechanisms of osteopenia in Rett syndrome: bone histomorphometric studies","volume":"18","author":"Budden","year":"2003","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.bone.2017.03.040_bb0190","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/BF02547219","article-title":"Effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) and dichloromethylene diphosphonate (Cl 2 MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats","volume":"11","author":"Schenk","year":"1973","journal-title":"Calcif. Tissue Res."},{"key":"10.1016\/j.bone.2017.03.040_bb0195","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1254\/jphs.FMJ05004X2","article-title":"Current topics in pharmacological research on bone metabolism: inhibitory effects of bisphosphonates on the differentiation and activity of osteoclasts","volume":"100","author":"Suzuki","year":"2006","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.bone.2017.03.040_bb0200","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.bone.2011.04.022","article-title":"Bisphosphonates: the first 40years","volume":"49","author":"Russell","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.03.040_bb0205","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.aanat.2011.03.009","article-title":"Short-term effects of zoledronate on the histomorphology of osteoclast in young albino rats","volume":"193","author":"Ralte","year":"2011","journal-title":"Ann. Anat."},{"key":"10.1016\/j.bone.2017.03.040_bb0210","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s10735-015-9620-9","article-title":"Histochemical evidence of zoledronate inhibiting c-src expression and interfering with CD44\/OPN-mediated osteoclast adhesion in the tibiae of mice","volume":"46","author":"Liu","year":"2015","journal-title":"J. Mol. Histol."},{"key":"10.1016\/j.bone.2017.03.040_bb0215","first-page":"S499","article-title":"Rett syndrome: bone mass in girls and mice","volume":"22","author":"Shapiro","year":"2007","journal-title":"Am. J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.03.040_bb0220","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000369582","article-title":"The long-term effects of switching from active intravenous bisphosphonate treatment to low-dose maintenance therapy in children with osteogenesis imperfecta","volume":"83","author":"Biggin","year":"2015","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.bone.2017.03.040_bb0225","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1002\/jbmr.1784","article-title":"Differing effects of PTH 1-34, PTH 1-84, and zoledronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis: an 18-month open-labeled observational study using HR-pQCT","volume":"28","author":"Hansen","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.03.040_bb0230","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/pr.2013.252","article-title":"Low bone turnover phenotype in Rett syndrome: results of biochemical bone marker analysis","volume":"75","author":"Roende","year":"2014","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.bone.2017.03.040_bb0235","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.bone.2010.10.159","article-title":"Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: what we think we know and what we know that we don't know","volume":"49","author":"Allen","year":"2011","journal-title":"Bone"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217301096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217301096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T07:54:43Z","timestamp":1535961283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328217301096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":47,"alternative-id":["S8756328217301096"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2017.03.040","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Zoledronic acid improves bone histomorphometry in a murine model of Rett syndrome","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2017.03.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}